Request Your Free Trend Report Now:

"Top market strategies for today's pharma landscape"

The complexity of turning a new drug into a successful asset remains a hurdle even beyond the coveted FDA approval.

As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.

Included in this trendline:

• Biogen scores Cannes Festival win with dark humored campaign
• Is DTC pharma advertising coming to an end?
• Megablockbusters are the holy grail. Here’s how drugmakers are getting there.

Offered Free by: PharmaVoice and Quest Diagnostics
See All Resources from: PharmaVoice and Quest Diagnostics